Cardiol Therapeutics (CRDL) Appoints Jennifer M. Chao to Its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to Cardiol Therapeutics (CRDL) Appoints Jennifer M. Chao to Its Board

Cardiol Therapeutics Appoints Jennifer M. Chao to Its Board of Directors

March 15, 2022 7:29 AM EDT

Oakville, Ontario--(Newsfile Corp. - March 15, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease ("CVD"), is pleased to announce that its Board of Directors has appointed Jennifer M. Chao to serve as a director, effective immediately. Ms. Chao has also been appointed Chair of the Corporate Governance and Compensation Committee.

Ms. Chao has over 25 years of experience in the biotech and life sciences industries focused primarily on finance and... More